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Primary PBT was well tolerated  and  3 years  after we didn´t report any recurrence of the 
tumour neither evidence of metastatic disease .The main complication was cataract, since in 
the eye, the lens is the most radiosensitive tissue. 
♂, 8 years  
Pigmented lesion in the 
inferotemporal iris of the left eye 
 Iris Nevus  
6 months later , the lesion grown in 
diameter and thickness associated with 
corectopia and ectropion uveae but did not 
involve the angle or ciliary body   
Diffuse Iris Melanoma  
It was performed PBT 
18-months, after PBT,  the patient developed a posterior 
subcapsular cataract in OS 
At age of 11, it was performed a micro-incision 
phacoemulsification cataract surgery combined with  
primary posterior capsulorexis, intracameral  
triamcinolone injection and implantation of a simple  
piece intraocular lens. No intra-operative  
complications were observed 
After 9 months of follow up,  the BCVA is 20/20 in OS , without complications 
Cataracts due to radiation are more linked to be posterior capsular opacities and it is advisable 
to wait 2 years after PBT prior to performing cataract surgery , in order to observe a good 
regression of the tumour. 
Surgeons should be aware that capsule is sometimes difficult to clean and that inflammatory 
reactions after surgery can be severer than for a standard surgery.  
Paediatric cataract surgery is also a complex procedure with all aspects of the surgical process 
requiring care and attention .The use of micro-incision phacoemulsification with intracameral 
triamcinolone and posterior capsulorexis seems to provide significantly less anterior segment 
inflammation and no visual axis obscuration after cataract surgery with IOL implantation. 
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